🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase II, randomized, double-blind, placebo-controlled multicente...
Status
Completed
Location
Multiple Locations
Start Date
2009-09
Trial ID
NCT00962832
Treatments Being Tested
The purpose of this study is to learn about the safety and effects of the s...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-09-10
Trial ID
NCT07782450
Treatments Being Tested
Lupus nephritis (LN) develops in 30-60% of systemic lupus erythematosus (SL...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-04-01
Trial ID
NCT07505576
This is a first exploration of GLPG3970 in subjects with active systemic lu...
Status
Terminated
Location
Medical center Medconsult Pleven
Start Date
2020-12-28
Trial ID
NCT04700267
Treatments Being Tested
Systemic lupus erythematosis (SLE) is a chronic autoimmune disease characte...
Status
Unknown
Location
Multiple Locations
Start Date
2022-02-22
Trial ID
NCT05253638
Treatments Being Tested
The goal of this clinical trial is to evaluate the safety and effectiveness...
Status
Recruiting
Location
Medical University of South Carolina
Start Date
2025-01-07
Trial ID
NCT06737380
Treatments Being Tested
The purpose of this study is to evaluate the efficacy of ustekinumab as mea...
Status
Completed
Location
Multiple Locations
Start Date
2015-10-15
Trial ID
NCT02349061
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of rapcabt...
Status
Recruiting
Location
University Of Alabama
Start Date
2024-09-04
Trial ID
NCT06581198
Treatments Being Tested
This case-control study aims to explore the relationship between specific b...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-05-01
Trial ID
NCT06872086
The purpose of this study is to evaluate the efficacy and safety of telitac...
Status
Terminated
Location
Anniston, Alabama Site
Start Date
2022-06-20
Trial ID
NCT05306574
Treatments Being Tested